← Evidence map

ArticleClinical and experimental immunology2026

Dysregulated complement activation in COVID-19: the role of soluble complement inhibitors.

Stef van der Meulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42885872